Grayson Wilkes Armstrong, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eye Injuries, Penetrating | 13 | 2024 | 122 | 6.760 |
Why?
|
Eye Injuries | 9 | 2023 | 227 | 3.510 |
Why?
|
Ophthalmology | 9 | 2024 | 550 | 2.210 |
Why?
|
Telemedicine | 9 | 2024 | 3051 | 1.420 |
Why?
|
Eye Diseases | 6 | 2024 | 653 | 1.170 |
Why?
|
Eye Foreign Bodies | 3 | 2024 | 51 | 1.150 |
Why?
|
Visual Acuity | 12 | 2024 | 2676 | 1.130 |
Why?
|
Cataract | 2 | 2023 | 828 | 1.050 |
Why?
|
Anterior Eye Segment | 2 | 2024 | 143 | 1.020 |
Why?
|
Lacerations | 1 | 2023 | 147 | 0.790 |
Why?
|
Lenses, Intraocular | 1 | 2023 | 139 | 0.790 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2022 | 76 | 0.780 |
Why?
|
Lens, Crystalline | 1 | 2023 | 385 | 0.760 |
Why?
|
Tomography, Optical Coherence | 8 | 2021 | 2923 | 0.740 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.730 |
Why?
|
Blindness | 3 | 2024 | 585 | 0.710 |
Why?
|
Retinal Detachment | 2 | 2022 | 429 | 0.700 |
Why?
|
Retinal Artery | 1 | 2021 | 109 | 0.690 |
Why?
|
Eye Infections, Bacterial | 2 | 2024 | 241 | 0.690 |
Why?
|
Corneal Diseases | 2 | 2022 | 539 | 0.680 |
Why?
|
Cataract Extraction | 1 | 2023 | 463 | 0.650 |
Why?
|
Oculomotor Muscles | 1 | 2023 | 405 | 0.640 |
Why?
|
Keratitis | 1 | 2022 | 240 | 0.630 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2024 | 353 | 0.630 |
Why?
|
Posterior Eye Segment | 1 | 2018 | 18 | 0.630 |
Why?
|
Cavernous Sinus | 1 | 2019 | 123 | 0.610 |
Why?
|
Ophthalmoplegia | 1 | 2019 | 168 | 0.600 |
Why?
|
Blepharoptosis | 1 | 2019 | 144 | 0.600 |
Why?
|
Emergencies | 1 | 2023 | 1217 | 0.550 |
Why?
|
Presenilin-1 | 1 | 2021 | 660 | 0.550 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 445 | 0.540 |
Why?
|
Aneurysm | 1 | 2019 | 337 | 0.530 |
Why?
|
Device Removal | 1 | 2021 | 629 | 0.520 |
Why?
|
Curriculum | 5 | 2022 | 3741 | 0.490 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2756 | 0.450 |
Why?
|
Retrospective Studies | 26 | 2024 | 80674 | 0.450 |
Why?
|
Recovery of Function | 1 | 2024 | 2981 | 0.440 |
Why?
|
Communicable Diseases | 1 | 2022 | 873 | 0.440 |
Why?
|
Carotid Artery Diseases | 1 | 2019 | 877 | 0.420 |
Why?
|
Retinal Drusen | 3 | 2017 | 75 | 0.410 |
Why?
|
Diabetic Retinopathy | 3 | 2019 | 1276 | 0.400 |
Why?
|
Wounds, Nonpenetrating | 1 | 2018 | 808 | 0.390 |
Why?
|
Artificial Intelligence | 3 | 2022 | 2576 | 0.380 |
Why?
|
Policy Making | 1 | 2015 | 541 | 0.380 |
Why?
|
Choroid | 3 | 2019 | 363 | 0.380 |
Why?
|
Endophthalmitis | 2 | 2024 | 260 | 0.370 |
Why?
|
Writing | 1 | 2013 | 199 | 0.370 |
Why?
|
Fractures, Bone | 1 | 2023 | 2046 | 0.360 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 4014 | 0.360 |
Why?
|
Macular Edema | 1 | 2014 | 374 | 0.350 |
Why?
|
Lens Implantation, Intraocular | 2 | 2023 | 190 | 0.340 |
Why?
|
Emergency Service, Hospital | 5 | 2023 | 7865 | 0.330 |
Why?
|
Inpatients | 1 | 2021 | 2545 | 0.320 |
Why?
|
Health Services | 1 | 2014 | 750 | 0.320 |
Why?
|
Eye | 3 | 2023 | 713 | 0.320 |
Why?
|
Accidents, Traffic | 1 | 2014 | 816 | 0.310 |
Why?
|
Humans | 54 | 2024 | 761208 | 0.290 |
Why?
|
Fluorescein Angiography | 6 | 2019 | 1062 | 0.270 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 1072 | 0.260 |
Why?
|
Cornea | 2 | 2022 | 1327 | 0.240 |
Why?
|
Cross-Sectional Studies | 9 | 2023 | 26071 | 0.230 |
Why?
|
Retinal Pigment Epithelium | 2 | 2017 | 303 | 0.220 |
Why?
|
Students, Medical | 1 | 2017 | 1940 | 0.220 |
Why?
|
Health Policy | 1 | 2015 | 2679 | 0.210 |
Why?
|
Mucopolysaccharidoses | 1 | 2022 | 27 | 0.200 |
Why?
|
Remote Consultation | 1 | 2024 | 237 | 0.200 |
Why?
|
Mucopolysaccharidosis I | 1 | 2022 | 52 | 0.190 |
Why?
|
Pandemics | 4 | 2024 | 8663 | 0.190 |
Why?
|
Diplopia | 1 | 2023 | 214 | 0.190 |
Why?
|
Female | 29 | 2024 | 392544 | 0.190 |
Why?
|
Education, Medical | 1 | 2013 | 1725 | 0.180 |
Why?
|
Vitrectomy | 1 | 2024 | 391 | 0.180 |
Why?
|
Aged | 17 | 2024 | 169288 | 0.180 |
Why?
|
Male | 24 | 2024 | 360693 | 0.180 |
Why?
|
Anterior Chamber | 1 | 2021 | 194 | 0.180 |
Why?
|
Keratoconus | 1 | 2022 | 113 | 0.170 |
Why?
|
Optometry | 1 | 2020 | 29 | 0.170 |
Why?
|
Colombia | 1 | 2021 | 282 | 0.170 |
Why?
|
Smoking | 1 | 2017 | 9055 | 0.170 |
Why?
|
School Admission Criteria | 1 | 2020 | 107 | 0.170 |
Why?
|
Alzheimer Disease | 1 | 2021 | 8603 | 0.160 |
Why?
|
Young Adult | 11 | 2024 | 59221 | 0.160 |
Why?
|
Vision, Low | 1 | 2021 | 163 | 0.160 |
Why?
|
Ophthalmoscopy | 1 | 2019 | 171 | 0.160 |
Why?
|
Personnel Selection | 1 | 2020 | 196 | 0.160 |
Why?
|
Sclera | 1 | 2020 | 189 | 0.150 |
Why?
|
Financial Management | 1 | 2020 | 160 | 0.150 |
Why?
|
Phacoemulsification | 1 | 2020 | 150 | 0.150 |
Why?
|
Corneal Transplantation | 1 | 2022 | 322 | 0.150 |
Why?
|
Choroiditis | 1 | 2017 | 12 | 0.150 |
Why?
|
Middle Aged | 16 | 2024 | 220853 | 0.150 |
Why?
|
Bruch Membrane | 1 | 2017 | 65 | 0.150 |
Why?
|
Professional Practice | 1 | 2020 | 313 | 0.150 |
Why?
|
Varicose Veins | 1 | 2019 | 156 | 0.150 |
Why?
|
Photography | 1 | 2021 | 532 | 0.140 |
Why?
|
Face | 1 | 2023 | 1025 | 0.140 |
Why?
|
Rupture | 1 | 2018 | 443 | 0.140 |
Why?
|
Age of Onset | 2 | 2021 | 3307 | 0.140 |
Why?
|
Trauma Severity Indices | 1 | 2018 | 478 | 0.140 |
Why?
|
Fovea Centralis | 1 | 2017 | 126 | 0.140 |
Why?
|
Private Sector | 1 | 2020 | 394 | 0.140 |
Why?
|
Mutation | 1 | 2021 | 30002 | 0.130 |
Why?
|
Otolaryngology | 1 | 2023 | 693 | 0.130 |
Why?
|
Prognosis | 4 | 2024 | 29687 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.130 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1273 | 0.130 |
Why?
|
Steroids | 1 | 2020 | 929 | 0.120 |
Why?
|
Wet Macular Degeneration | 1 | 2017 | 162 | 0.120 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39126 | 0.120 |
Why?
|
Italy | 1 | 2017 | 844 | 0.120 |
Why?
|
Retinal Vessels | 2 | 2017 | 854 | 0.120 |
Why?
|
Adult | 13 | 2024 | 221119 | 0.110 |
Why?
|
Adolescent | 8 | 2024 | 88298 | 0.110 |
Why?
|
Choroidal Neovascularization | 1 | 2017 | 364 | 0.110 |
Why?
|
Educational Measurement | 1 | 2020 | 1250 | 0.110 |
Why?
|
Fundus Oculi | 3 | 2022 | 557 | 0.110 |
Why?
|
United States | 9 | 2023 | 72339 | 0.110 |
Why?
|
Retinal Neovascularization | 1 | 2016 | 288 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1432 | 0.100 |
Why?
|
Child, Preschool | 5 | 2024 | 42224 | 0.100 |
Why?
|
Sex Factors | 2 | 2017 | 10553 | 0.100 |
Why?
|
Massachusetts | 1 | 2024 | 8837 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3608 | 0.090 |
Why?
|
Eye Pain | 2 | 2022 | 46 | 0.090 |
Why?
|
Angiography | 1 | 2016 | 1597 | 0.090 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2013 | 166 | 0.090 |
Why?
|
Infant | 3 | 2021 | 36169 | 0.090 |
Why?
|
Internship and Residency | 2 | 2020 | 5885 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2019 | 1304 | 0.080 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2019 | 1186 | 0.080 |
Why?
|
Age Factors | 2 | 2017 | 18384 | 0.080 |
Why?
|
Child | 6 | 2024 | 80152 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2019 | 1935 | 0.070 |
Why?
|
Boston | 1 | 2021 | 9327 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20588 | 0.070 |
Why?
|
Sex Distribution | 1 | 2012 | 2277 | 0.070 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2019 | 2157 | 0.070 |
Why?
|
Medicare | 2 | 2023 | 6773 | 0.070 |
Why?
|
Medicaid | 1 | 2019 | 2813 | 0.060 |
Why?
|
Age Distribution | 1 | 2012 | 2871 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2056 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4788 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4642 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15308 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12976 | 0.060 |
Why?
|
Prospective Studies | 4 | 2022 | 54435 | 0.050 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 2022 | 20 | 0.050 |
Why?
|
Cognition | 1 | 2021 | 6988 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2014 | 26199 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2021 | 22174 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16575 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3885 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13511 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5425 | 0.050 |
Why?
|
Databases, Factual | 2 | 2020 | 7966 | 0.050 |
Why?
|
Keratoplasty, Penetrating | 1 | 2022 | 143 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2012 | 1920 | 0.040 |
Why?
|
Pseudophakia | 1 | 2020 | 60 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15721 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17897 | 0.040 |
Why?
|
Specialty Boards | 1 | 2020 | 235 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 617 | 0.040 |
Why?
|
Demyelinating Diseases | 1 | 2020 | 352 | 0.040 |
Why?
|
Colloids | 1 | 2017 | 123 | 0.040 |
Why?
|
Geography | 1 | 2020 | 652 | 0.040 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58952 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 350 | 0.030 |
Why?
|
Pediatrics | 1 | 2012 | 3590 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2017 | 234 | 0.030 |
Why?
|
Coloring Agents | 1 | 2017 | 561 | 0.030 |
Why?
|
Triage | 1 | 2022 | 985 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 561 | 0.030 |
Why?
|
Vision Disorders | 1 | 2022 | 1088 | 0.030 |
Why?
|
Intraocular Pressure | 1 | 2020 | 1294 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 751 | 0.030 |
Why?
|
Accidents, Home | 1 | 2013 | 71 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2016 | 1498 | 0.030 |
Why?
|
Syndrome | 1 | 2017 | 3271 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1369 | 0.020 |
Why?
|
Testosterone | 1 | 2019 | 2472 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21365 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2374 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8457 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4190 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74239 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2020 | 3222 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5426 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4052 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 39957 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5842 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14025 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64681 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36415 | 0.010 |
Why?
|